StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)

Close on Nov 18, 2026Market cap $247.14MP/E –Yield –

ClearPoint Neuro operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

ClearPoint Neuro's operating income for the twelve months ending Sep 30, 2026 was -$32.10M. For fiscal 2025 it was -$24.16M. The highest annual figure on record is -$3.13M in fiscal 2012.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$24.16M–
FY2024Dec 31, 2024-$19.73M–
FY2023Dec 31, 2023-$22.45M–
FY2022Dec 31, 2022-$16.33M–
FY2021Dec 31, 2021-$13.37M–
FY2020Dec 31, 2020-$6.22M–
FY2019Dec 31, 2019-$4.59M–
FY2018Dec 31, 2018-$5.25M–
FY2017Dec 31, 2017-$6.34M–
FY2016Dec 31, 2016-$7.49M–
FY2015Dec 31, 2015-$8.97M–
FY2014Dec 31, 2014-$5.32M–
FY2013Dec 31, 2013-$7.47M–
FY2012Dec 31, 2012-$3.13M–
FY2011Dec 31, 2011-$5.92M–
FY2010Dec 31, 2010-$9.52M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$6.33M–
Q2 FY2026Jun 30, 2026-$10.24M–
Q1 FY2026Mar 31, 2026-$8.48M–
Q4 FY2025Dec 31, 2025-$7.05M–
Q3 FY2025Sep 30, 2025-$5.28M–
Q2 FY2025Jun 30, 2025-$5.68M–
Q1 FY2025Mar 31, 2025-$6.16M–
Q4 FY2024Dec 31, 2024-$5.64M–
Q3 FY2024Sep 30, 2024-$5.16M–
Q2 FY2024Jun 30, 2024-$4.72M–
Q1 FY2024Mar 31, 2024-$4.22M–
Q4 FY2023Dec 31, 2023-$4.71M–
Q3 FY2023Sep 30, 2023-$4.90M–
Q2 FY2023Jun 30, 2023-$7.13M–
Q1 FY2023Mar 31, 2023-$5.71M–
Q4 FY2022Dec 31, 2022-$4.47M–
Q3 FY2022Sep 30, 2022-$3.80M–
Q2 FY2022Jun 30, 2022-$4.20M–
Q1 FY2022Mar 31, 2022-$3.86M–
Q4 FY2021Dec 31, 2021-$3.98M–
Q3 FY2021Sep 30, 2021-$3.80M–
Q2 FY2021Jun 30, 2021-$3.41M–
Q1 FY2021Mar 31, 2021-$2.18M–
Q4 FY2020Dec 31, 2020-$2.27M–
Q3 FY2020Sep 30, 2020-$1.27M–
Q2 FY2020Jun 30, 2020-$1.48M–
Q1 FY2020Mar 31, 2020-$1.21M–
Q4 FY2019Dec 31, 2019-$1.42M–
Q3 FY2019Sep 30, 2019-$910.53K–
Q2 FY2019Jun 30, 2019-$1.29M–
Q1 FY2019Mar 31, 2019-$972.25K–
Q4 FY2018Dec 31, 2018-$979.02K–
Q3 FY2018Sep 30, 2018-$1.21M–
Q2 FY2018Jun 30, 2018-$1.64M–
Q1 FY2018Mar 31, 2018-$1.43M–
Q4 FY2017Dec 31, 2017-$1.83M–
Q3 FY2017Sep 30, 2017-$1.33M–
Q2 FY2017Jun 30, 2017-$1.82M–
Q1 FY2017Mar 31, 2017-$1.35M–
Q4 FY2016Dec 31, 2016-$1.79M–

More ClearPoint Neuro figures

See a number that looks wrong?